antibody

Documents about antibody

• Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients#807619ClinicalTrials.gov
• Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome#882083ClinicalTrials.gov
• Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Cerebral Cortical Encephalitis: A Comparative Study With Antibody‐Negative and Non‐MOG Antibody‐Positive Cortical Encephalitis in Chinese Adults.#159971NCBI PubMed Central
• Analysis of Biopsies With Antibody Mediated Rejection According to the Therapy Response#828810ClinicalTrials.gov
• Improving Site-Specific Antibody Conjugation to Liposomes Using Co-PoP and LASIC#207047ScholarlyCommons at Penn
• Mechanisms of Neonatal Mucosal Antibody Protection#400285OpenAlex
• Engineering the antibody-TRIM21 interface for the improved intracellular clearance of pathogenic targets#325040Apollo
• CoaguChek XS in Antiphospholipid Antibody Syndrome (APL) Patients#841640ClinicalTrials.gov
• EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma#804858ClinicalTrials.gov
• 3BNC117 Monoclonal Antibody in HIV-infected Subjects During Treatment Interruption#869735ClinicalTrials.gov
• At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study#872830ClinicalTrials.gov
• CASPR2 Encephalitis Initial Symptoms#885051ClinicalTrials.gov
• Safety and Targeting of Anti-hk2 Antibody in mCRPC#889565ClinicalTrials.gov
• Development of a mast cell depleting antibody for the treatment of mastocytosis#370759HAL (France)
• DEP Combine With PD-1 Antibody as an Treatment for EBV-HLH#811308ClinicalTrials.gov
• Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine#870427ClinicalTrials.gov
• Antibody repertoire profiling during pregnancy and proteome-wide internal degron mapping#347591Harvard DASH
• The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma#848198ClinicalTrials.gov
• The Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN)#890770ClinicalTrials.gov
• STRUCTURAL STUDIES OF ANTIBODY: ALPHAVIRUS COMPLEXES AND MUTANT ALPHAVIRUS THAT COULD POTENTIALLY BE A VACCINE CANDIDATE#254776ScholarBank@NUS
• Immunotherapy in Intractable Cryptogenic Epilepsy Patients With Autoimmune Antibody#883704ClinicalTrials.gov
• The ImmPort Antibody Ontology#721526PhilArchive
• Multidimensional maturation of antibody variable domains with machine-learning assistance.#9737PubMed
• Protein Expression Profiling of Formalin-Fixed Paraffin-Embedded Tissue Using Recombinant Antibody Microarrays#452371Lund University Publications
• Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis#849674ClinicalTrials.gov
• Daratumumab for Late Antibody-Mediated Rejection#887926ClinicalTrials.gov
• Study of SHR2150 (TLR7 Agonist) in Combination With Chemotherapy Plus PD-1 or CD47 Antibody in Subjects With Unresectable/ Metastatic Solid Tumors#856828ClinicalTrials.gov
• Extracellular payload release from non-internalizing antibody-drug conjugates: mechanisms and linker technologies#4525Europe PMC
• AbDist: a lightweight, distance-based model for antibody affinity prediction as an interpretable benchmark for machine learning models.#9668PubMed
• Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer#853122ClinicalTrials.gov
• Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection#892363ClinicalTrials.gov
• Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer#869665ClinicalTrials.gov
• Prediction of antibody non-specificity using protein language models and biophysical parameters.#236548PubMed
• Biofilm-derived curli and Z-DNA shape anti-DNA antibody responses during Salmonella infections#368466PLOS
• Study of CHO-A04 in Advanced Solid Tumors#833561ClinicalTrials.gov
• FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer#834282ClinicalTrials.gov
• First in class monoclonal antibody potentiating human follicle stimulating hormone activity improves spermatogenesis in azoospermic rodent models#304526HAL (France)
• Case Report: Eosinophilic fasciitis with PM-Scl antibody positivity: expanding the serological spectrum#453507ULRR
• Mosunetuzumab: A bispecific CD20 × CD3 antibody for follicular lymphoma with promising evidence in other B-NHL subtypes#651918Europe PMC
• Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine#801565ClinicalTrials.gov
• A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201)#831852ClinicalTrials.gov
• Lenvatinib Plus PD-1 Antibody vs TACE for Intermediate-stage HCC Beyond Up-to-seven Criteria#856595ClinicalTrials.gov
• Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children#881504ClinicalTrials.gov
• A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors#885682ClinicalTrials.gov
• Modeling of antibody waning after heterologous boosting with Ad5-nCoV in individuals primed with two-dose CoronaVac previously#5161Europe PMC
• Antibody Response Against SARS-CoV-2 Spike Protein in People with HIV After COVID-19 Vaccination.#281629Repisalud
• DyAb: sequence-based antibody design and property prediction in a low-data regime.#615980PubMed
• CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis#830497ClinicalTrials.gov
• Study to Evaluate Safety and Pharmacokinetics of UB-421 Antibody in HIV-1 Infected Adults#840369ClinicalTrials.gov
• Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer#864655ClinicalTrials.gov